Reliability of sentinel node assay in vulvar cancer: The first Croatian validation trial

Gynecologic Oncology

Volumn 126, Issue 1, 2012, Pages 99-102

  Zekan, Josko ^a   Mutvar, Andrea ^a   Huic, Drazen ^a   Petrovic, Davor ^b   Karelovic, Deni ^c   Mitrovic, Leila ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Immunohistochemical staining; Lymphoscintigraphy; Sentinel lymph node; Vulvar cancer

Indexed keywords

ALBUMIN TC 99M COLLOID;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CROATIA; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPHOSCINTIGRAPHY; MICROMETASTASIS; PATIENT SELECTION; PELVIS LYMPHADENECTOMY; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PUNCH BIOPSY; RELIABILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; VALIDATION PROCESS; VULVA CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CROATIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 84862772225     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.04.001     Document Type: Article

References (53)

1. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 4th ed. Philadelphia, PA: LippincottWilliams &Wilkins; 2005. p. 585-602.
2. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006;107:1018-22.
3. Croatian National Cancer Registry, Bulletin No. 34; 2011. Zagreb.
4. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164:997-1003.
5. Ghurani GB, Penalver MA. An update on vulvar cancer. Am J Obstet Gynecol 2001;185:294-9. (Pubitemid 32769426)
6. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000;45:613-5. (Pubitemid 30661117)
7. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997;90:448-52. (Pubitemid 27357940)
8. Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol 2008;109:340-5.
9. Joura EA. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia. Curr Opin Obstet Gynecol 2002;14:39-43. (Pubitemid 34177906)
10. de Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006;60:38-58. (Pubitemid 44332964)
11. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
12. Finan MA, Barre G. Bartholin's gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Pract Res Clin Obstet Gynaecol 2003;17:609-33. (Pubitemid 37168283)
13. Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol 2006;107:719-33.
14. Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 2003;196:442-50. (Pubitemid 36343646)
15. Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003;13:522-7. (Pubitemid 38220673)
16. van der Velden J, Hacker NF. Prognostic factors in squamous cell cancer of the vulva and the implications for treatment. Curr Opin Obstet Gynecol 1996;8:3-7. (Pubitemid 26112536)
17. Saito T, Kato K. Management of lymph nodes in the treatment of vulvar cancer. Int J Clin Oncol 2007;12:187-91. (Pubitemid 46944640)
18. Cabanas RM. The concept of the sentinel lymph node. Recent Results Cancer Res 2000;157:109-20.
19. Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994;84:163-7. (Pubitemid 24234819)
20. Canavan TP, Cohen D. Vulvar cancer. Am Fam Physician 2002;66:1269-74.
21. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
22. de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998;39:1381-5. (Pubitemid 28373561)
23. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993;2:137-43. (Pubitemid 23255936)
24. Devaja O, Mehra G, Coutts M, Adamson S, Montalto SA, Donaldson J, et al. A prospective study of sentinel lymph node detection in vulval carcinoma: is it time for a change in clinical practice? Int J Gynecol Cancer 2011;21:559-64.
25. Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000;76:40-4. (Pubitemid 30048317)
26. Hakam A, Nasir A, Raghuwanshi R, Smith PV, Crawley S, Kaiser HE, et al. Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res 2004;24:1281-6. (Pubitemid 38624976)
27. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 1993;49:279-83. (Pubitemid 23191198)
28. de Hullu JA, Oonk MH, van der Zee AG. Modern management of vulvar cancer. Curr Opin Obstet Gynecol 2004;16:65-72. (Pubitemid 38241544)
29. Oonk MH, van Os MA, de Bock GH, de Hullu JA, Ansink AC, van der Zee AG. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 2009;113:301-5.
30. Yoder BJ, Rufforny I, Massoll NA, Wilkinson EJ. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk. Am J Surg Pathol 2008;32:765-72. (Pubitemid 351600822)
31. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
32. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7. (Pubitemid 27270119)
33. DeCesare SL, Fiorica JV, Roberts WS, Reintgen D, Arango H, Hoffman MS, et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 1997;66:425-8. (Pubitemid 27388134)
34. De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000;82:295-9. (Pubitemid 30045373)
35. Sideri M, De Cicco C, Maggioni A, Colombo N, Bocciolone L, Trifirò G, et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori 2000;86:359-63. (Pubitemid 30644928)
36. Boran N, Kayikcioglu F, Kir M. Sentinel lymph node procedure in early vulvar cancer. Gynecol Oncol 2003;90:492-3. (Pubitemid 36952056)
37. Merisio C, Berretta R, Gualdi M, Pultrone DC, Anfuso S, Agnese G, et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer 2005;15:493-7. (Pubitemid 40705546)
38. Hampl M, Hantschmann P, Michels W, Hillemanns P, German Multicenter Study Group. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 2008;111:282-8.
39. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983;16:179-89. (Pubitemid 13014831)
40. Leong WL, Ghazarian DM, McCready DR. Previous wide excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk extremity. J Surg Oncol 2003;82:143-6. (Pubitemid 36278259)
41. Javan H, Gholami H, Assadi M, Pakdel AF, Sadeghi R, Keshtgar M. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion: systematic review and meta-analysis of the literature. Eur J Surg Oncol 2012;38:95-109.
42. Stehman FB, Ali S, DiSaia PJ. Node count and groin recurrence in early vulvar cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2009;113:52-6.
43. van der Velden J. Some aspects of the management of squamous cell carcinoma of the vulva. PhD Thesis. Amsterdam, The Netherlands; 1996.
44. de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2811-6. (Pubitemid 30620069)
45. Ansink AC, Sie-Go DM, van der Velden J, Sijmons EA, de Barros Lopes A, Monaghan JM, et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer 1999;86:652-6. (Pubitemid 29379411)
46. Lindell G, Jonsson C, Ehrsson RJ, Jacobsson H, Danielsson KG, Källström BN, et al. Evaluation of preoperative lymphoscintigraphy and sentinel node procedure in vulvar cancer. Eur J Obstet Gynecol Reprod Biol 2010;152:91-5.
47. Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph node in vulvar cancer. Cancer 2007;110:1015-23. (Pubitemid 47312867)
48. Louis-Sylvestre C, Evangelista E, Leonard F, Itti E, Meignan M, Paniel BJ. Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol 2005;97:151-4. (Pubitemid 40403687)
49. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995;57:327-34.
50. Kirby TO, Rocconi RP, Numnum TM, Kendrick JE, Wright J, Fowler W, et al. Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 2005;98:309-12. (Pubitemid 41019122)
51. de Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002;95:2331-8. (Pubitemid 35351139)
52. Levenback CF. How safe is sentinel lymph node biopsy in patients with vulvar cancer? J Clin Oncol 2008;26:828-9. (Pubitemid 351398070)
53. van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884-9. (Pubitemid 351398080)